Research Studies

We are continuous working with new lines of treatment that have become the new hope for many patients.

Breast

Type of Cancer: Breast Sponsor: Sanofi Phase / Design: Phase 2 Randomized Open label Population: Locally advanced Not amenable to surgery / Radio the OR Metastatic Disease ER (+) &…

Breast

Type of Cancer: Breast Sponsor: Sanofi Phase / Design: Phase 2 Window Study Population: Localized & operable: Stage IIStage III Newly diagnosed, Pre-operative post-menopausal ER(+) & HER-2 (-)

Breast Cancer

Type of Cancer: Breast Cancer Sponsor: Sanofi Phase / Design: A Randomized, Multicenter, Double-blind, Phase 3 Study for the Treatment of Patients with ER (+), HER2 (-) Breast Cancer who…

COVID-19

Type: COVID BI 764198 efficacy and safety in prevention/progression of ARDS and ARDS- related complications secondary to COVID-19 (ACTION ON COVID-19) Sponsor: Boeringher Ingelheim Phase / Design: Population:

Hepatocellular

Type of Cancer: Hepatocellular Sponsor: Merck Phase / Design: Phase 3 Randomized Double-blind Population: Incurable Nonmetastatic HCC No macrovascular invasion. Not amenable to transplant All lesions amenable to TACE in…

Lung

Type of Cancer: NSCLC Sponsor: BMS Phase / Design: Phase 3 Randomized Open label Population: Locally advanced: Stage IIIA, IIIB, or IIIC Unresectable Amenable to Chemoradiotherapy Naïve EGFR mutation (-)

Lung

Type of Cancer: NSCLC Sponsor: Merck Phase / Design: Phase 3 Randomized Open label (Rescue site) Population: Metastatic EGFR mutation (-)  

Lung

Type of Cancer: NSCLC Sponsor: BMS Phase / Design: Phase 3 Randomized Double-blind Population: Resectable Stage II-IIIB Naïve EGFR mutation (-)

Lung

Type of Cancer: Lung Sponsor: Mirati Phase / Design: A Randomized Phase 3 Study of MRTX849 versus Docetaxel Population: Patients with Previously Treated Non-Small Cell Lung Cancer with KRAS G12C…

Myeloma

Type of Cancer: Phase 1-2 trial evaluating anti-TGF agent (SAR439459) or pomalidomide in combination with isatuximab and dexamethasone in relapsed or refractory multiple myeloma (RRMM). Sponsor: Sanofi Phase / Design:…
Menu